Imaging Procedure

PROCEDURE10 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, OHSU Knight Cancer Institute, NRG Oncology, University College, London, National Cancer Institute (NCI)

Conditions

Acute Myeloid Leukemia Post Cytotoxic TherapyAdvanced Hepatocellular CarcinomaAdvanced NUT CarcinomaClinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Cutaneous MelanomaHead and Neck CancerHypopharynx CancerLow Grade Fallopian Tube Serous Adenocarcinoma

Phase 1

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial

SuspendedNCT04539366

National Cancer Institute (NCI)Recurrent Childhood Neuroblastoma, Recurrent Childhood Osteosarcoma, Recurrent Neuroblastoma +5

Start: 2022-01-25End: 2040-12-31Target: 67Updated: 2026-05-13

Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma

RecruitingNCT05019716

National Cancer Institute (NCI)Advanced NUT Carcinoma, Metastatic NUT Carcinoma, Unresectable NUT Carcinoma

Start: 2022-07-13End: 2026-06-30Target: 36Updated: 2026-05-13

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

RecruitingNCT06811116

National Cancer Institute (NCI)Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 +1

Start: 2025-11-17End: 2027-08-31Target: 92Updated: 2026-05-13

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

RecruitingNCT07012044

National Cancer Institute (NCI)Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia

Start: 2026-07-26End: 2027-03-31Target: 47Updated: 2026-05-19

Phase 2

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

RecruitingNCT06997068

Mayo ClinicClinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Cancer, Hypopharynx Cancer +15

Start: 2025-07-09End: 2028-06-30Target: 25Updated: 2026-05-11

Phase 3

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Active, not recruitingNCT04095364

NRG OncologyLow Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma +9

Start: 2019-09-20End: 2028-02-01Target: 450Updated: 2026-03-24

Unknown Phase

Which is the Most Reliable Radiologic Examination for the Diagnosis of Rotator Cuff Tendon Tear?

CompletedNCT00925366

Assistance Publique - Hôpitaux de ParisRotator Cuff Disease, Shoulder

Start: 2003-09-30End: 2009-06-30Updated: 2009-07-29

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

TerminatedNCT03699995

OHSU Knight Cancer InstituteCutaneous Melanoma, Melanocytic Nevus, Skin Carcinoma

Start: 2018-05-18End: 2025-12-31Updated: 2026-04-08

Lymphatic Mapping Of Oropharyngeal Cancer

RecruitingNCT04498221

University College, LondonOropharyngeal Cancer

Start: 2022-07-07End: 2027-01-31Target: 150Updated: 2024-09-19

Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

Active, not recruitingNCT06037863

Mayo ClinicProstate Carcinoma

Start: 2023-09-19End: 2027-12-30Updated: 2026-02-23

Related Papers

Lymphatic mapping Of Oropharyngeal Cancer (LOOC): protocol for a phase II surgical imaging trial to evaluate contralateral drainage and occult metastasis in oropharyngeal cancer

BMJ Open2025-06-01

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.

2022-05-0618 citations

A randomized phase III, two-arm trial of paclitaxel, carboplatin, and maintenance letrozole versus letrozole monotherapy in patients with stage II-IV, primary low-grade serous carcinoma of the ovary or peritoneum.

Journal of Clinical Oncology2021-05-2010 citations

Targeting Progesterone in Hormonally Responsive Ovarian Cancer

Oncology Times2019-11-26